GoPath Diagnostics’ Post

EGFR mutations play a significant role in lung cancer, with approximately one-third of cases presenting this mutation. Thanks to science, there have been major therapeutic breakthroughs in recent years, Yet these innovations can only make the most impact through early diagnosis so that patients can access these treatments at the right time. By identifying genetic predispositions through biomarker testing, we can intervene earlier and implement targeted measures, ensuring patients receive timely treatment. #PrecisionMedicine #LungCancer #InFrontOfCancer

Faster Results for Clinicians Treating Breast Cancer Patients Waiting for test results can be a big setback in clinical cancer care, especially if preventative treatment may be urgently required. The Everything Genetic 12 Gene Breast Cancer Panel is delivered from a UK laboratory, allowing you to receive clinically actionable results in just 2–3 weeks. This allows you to quickly determine best next steps for treatments and implement the right preventative care for your patients. By identifying the disease-causing variant, the 12 Gene Breast Cancer Panel can also guide testing and management of at-risk relatives. Find out more: https://buff.ly/3xbhT8d Listen what our Medical Director, Dr James Mackay, has to say about this test in the video below ⬇️ #BreastCancer #BreastCancerTest #GeneticTestForBreastCancer #12GenePanel #UKGeneticTest #GeneticTesting #NGSTesting #GeneticTest #BreastCancerRiskTest #BreastCancerRisk #CancerPrevention #CancerTreatment #CancerDiagnosis

🔬 Dive into the world of pan-cancer markers with our FREE infographic! Discover how these markers pave the way for universal diagnostic strategies, revolutionizing cancer detection by identifying common genetic mutations across diverse types. Don't miss out on understanding shared pathways in tumorigenesis. Download now: https://ow.ly/W9Jh50QWmVu #CancerResearch #PanCancerMarkers #UniversalDiagnostics #Infographic

Prevalence in South Asia of #EGFR mutations is approximately 30% and of #ALK fusions/rearrangements approximately 10% - highlighting the importance of predictive biomarker testing in all adenocarcinoma / non-squamous #NSCLC and other histological subtypes whenever clinically indicated. Targeted therapies have a significant impact on clinical outcomes when offered to patients selected based on results of biomarker testing. #LCSM

Can a simple tumour tissue test help identify the very best treatment for a cancer patient? Yes! This powerful, brand-new tumour RNA expression test is a game-changer for cancer patients and their doctors and looks at tumour based expression of just under 21,000 genes. It can help determine the exact right treatment(s) for a patient… (More accurately than DNA genetic testing alone!) CTOAM’s cancer expert, Alex Rolland, made this video to explain more: The main takeaway? If you're not using this test in your diagnosis, you're likely missing out on better cancer treatments… Treatments that could help you live significantly longer, and with fewer side-effects, than the treatment you're currently on… And that could even help you become cancer-free, like many of our patients! Apply for a Precision Second Opinion to find out what your best treatment options are, today: https://buff.ly/2sDA3yx #PrecisionCancerMedicine #HopeIsHere

Targeted therapies, designed to treat specific genetic mutations like EGFR, ALK, and ROS1, are offering improved outcomes for patients, especially those with non-small cell lung cancer. This approach tailors treatment to each individual’s genetic profile, maximizing effectiveness. Let’s continue supporting personalized cancer care! #LCAM24

🔬 BRCA1/2 gene mutations play a pivotal role in breast cancer diagnosis and treatment planning, making accurate detection more crucial than ever. LGC Clinical Diagnostics provide advanced tools and solutions to support laboratories in ensuring precise and reliable BRCA1/2 testing. This blog delves into the importance of comprehensive BRCA1/2 diagnostics, the use of certified reference materials, and how these innovations are empowering personalised breast cancer treatments. Explore how we’re helping labs deliver confidence in their results and advancing the future of breast cancer care: https://ow.ly/1F2b50TA2Uy #ScienceforaSaferWorld #BreastCancerAwarenessMonth #BRCA #ClinicalDiagnostics #PersonalisedMedicine #Genomics #PrecisionDiagnostics https://ow.ly/1F2b50TA2Uy

Our Empower Hereditary Cancer Test has five panel options with up to 81 genes across 12+ common hereditary cancer types, and customizable gene panels with 190+ gene options. Genes can be selected individually or added by selecting a particular organ system of interest. This test is particularly important for those who want to know more about their risk of developing cancer, why it might be common in their family, or want to inform treatment options following a cancer diagnosis. Learn more below. https://ow.ly/XINT50SZme9 #HereditaryCancer #Natera #KnowledgeisEmpower

To accommodate both biomarkers relevant today as well as biomarkers relevant in the (near) future, it is necessary to establish routine large-panel next-generation sequencing (NGS) for all patients with advanced stage Lung cancer. For cost-effectiveness and to facilitate equal access to biomarker testing to all patients, it is recommended to implement predictive molecular testing using large-panel NGS in a dedicated, centralized expert laboratory. Karkinos Healthcare Vinod Scaria Sridhar Sivasubbu

Can a simple tumour tissue test help identify the very best treatment for a cancer patient? Yes! This powerful, brand-new tumour RNA expression test is a game-changer for cancer patients and their doctors and looks at tumour based expression of just under 21,000 genes. It can help determine the exact right treatment(s) for a patient… (More accurately than DNA genetic testing alone!) CTOAM’s cancer expert, Alex Rolland, made this video to explain more: The main takeaway? If you're not using this test in your diagnosis, you're likely missing out on better cancer treatments… Treatments that could help you live significantly longer, and with fewer side-effects, than the treatment you're currently on… And that could even help you become cancer-free, like many of our patients! Apply for a Precision Second Opinion to find out what your best treatment options are, today: https://buff.ly/2sDA3yx #PrecisionCancerMedicine #HopeIsHere